Ritalin vs. Jornay PM

See how Ritalin and Jornay PM compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ritalin is taken two to three times a day and is also FDA-approved for narcolepsy, while Jornay PM is a once-daily evening capsule approved only for ADHD.

  • Both are methylphenidate stimulants that carry the same boxed warning for abuse, misuse, and addiction potential.

  • Generic Ritalin is widely available and inexpensive, while Jornay PM has no generic and typically costs several times more per month.

Ritalin vs. Jornay PM Drug Summary

Ritalin

Ritalin is a central nervous system stimulant in the methylphenidate class, prescribed for ADHD in patients 6 years and older and for narcolepsy. It is taken as an immediate-release tablet, usually 2 to 3 times a day, about 30 to 45 minutes before meals.

Jornay PM

Jornay PM is also a methylphenidate-based CNS stimulant, but it is approved only for ADHD in patients 6 years and older. It is taken once daily in the evening as a delayed-release capsule, so it starts working before the patient wakes and covers symptoms into the next day.

Ritalin vs. Jornay PM Side Effects

Ritalin

Most common
Headache (up to 14%)
Decreased appetite (up to 8%)
Insomnia (up to 4%)
Anxiety (up to 8%)

Jornay PM

Most common
Headache (up to 19%)
Decreased appetite (up to 27%)
Insomnia (up to 41%)
Affect lability (up to 22%)

Ritalin vs. Jornay PM Dosage

Ritalin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg twice daily At the start
Maximum dose Up to 60 mg/day If needed
Dose changes 3 increases As tolerated

Jornay PM

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg once daily At the start
Maximum dose 100 mg once daily If needed
Dose changes 4 increases As tolerated

Ritalin vs. Jornay PM Indications

Ritalin

Ritalin is FDA-approved to treat ADHD in patients 6 years and older, as part of a broader treatment plan that may include therapy. It is also approved for narcolepsy, a sleep disorder marked by sudden episodes of daytime sleepiness.

  • ADHD in children, teens, and adults 6+

  • Narcolepsy in adults and children

  • Off-label: used for treatment-resistant depression

  • Off-label: sometimes used for cancer-related fatigue

Jornay PM

Jornay PM is FDA-approved to treat ADHD in patients 6 years and older, taken once daily in the evening so it works while a patient sleeps and continues through the next day. It carries no approval for narcolepsy or for children under 6.

  • ADHD in children, teens, and adults 6+

  • Not approved for children younger than 6

  • Not approved for narcolepsy

  • No generic version currently available

Ritalin vs. Jornay PM Pros and Cons

Ritalin

Ritalin has decades of real-world use and comes in immediate-release, sustained-release, and long-acting forms, plus low-cost generics. Because it is dosed multiple times a day, timing doses around school or work schedules takes more planning than a once-daily option.

Pros

  • Available as an inexpensive generic tablet

  • Also FDA-approved for narcolepsy, unlike Jornay PM

  • Multiple formulations (IR, SR, LA) allow flexible dosing

  • Roughly $25 to $100 a month without insurance, far less than Jornay PM

Cons

  • Needs 2 to 3 doses a day to maintain coverage

  • Effects wear off between doses, risking symptom rebound

  • Short duration of action compared to once-daily options

  • No delayed-release option for next-morning symptom control

Jornay PM

Jornay PM's evening dosing and delayed-release design mean symptom control can start before a patient even wakes up, without a dose at school or work. It is newer to market and has no generic, so it usually costs more out of pocket than standard methylphenidate.

Pros

  • Only one dose a day, taken in the evening

  • No midday redosing needed at school or work

  • Delayed-release design targets symptoms right at wake-up

  • Covers symptoms from wake-up through the next evening

Cons

  • No generic version; costs roughly $340 to $620 a month

  • Not approved for narcolepsy

  • Newer drug (since 2018) with less long-term real-world data

  • Missing the evening dose window can delay next-day coverage

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.